[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335850-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-335850-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","expression-level-and-clinical-significance-of-nbat-1-in-human-cancers-a-systematic-review-and-meta-analysis","Expression level and clinical significance of NBAT-1 in human cancers - a systematic review and meta-analysis","","A meta-analysis was conducted to quantify how NBAT-1 lncRNA expression relates to clinicopathological features and prognosis across human cancers. Using Web of Science and PubMed, independent study identification and screening produced 12 eligible studies totaling 1600 patients. Low NBAT-1 expression was significantly associated with distant metastasis, deep invasion, poor histological grade, advanced TNM stage, larger tumor volume, and lymph node metastasis. Reduced NBAT-1 predicted poor prognosis, supporting its value as a biomarker.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/expression-level-and-clinical-significance-of-nbat-1-in-human-cancers-a-systematic-review-and-meta-analysis/335850/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/expression-level-and-clinical-significance-of-nbat-1-in-human-cancers-a-systematic-review-and-meta-analysis/335850.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-09","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What was the goal of the systematic review and meta-analysis?","Question",{"text":63,"@type":64},"To determine the prognostic value of lncRNA NBAT-1 expression in cancer patients by quantifying its association with clinical features and outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were studies identified and selected?",{"text":68,"@type":64},"Two researchers independently searched Web of Science and PubMed, then performed literature screening using exclusion and admission criteria, followed by data extraction and statistical analysis in StataSE 12.0.",{"name":70,"@type":61,"acceptedAnswer":71},"Which clinical factors were associated with low NBAT-1 expression?",{"text":72,"@type":64},"Low NBAT-1 expression correlated with distant metastasis, deep tumor invasion, poor histological grade, advanced TNM stage, larger tumor volume, and lymph node metastasis.",{"name":74,"@type":61,"acceptedAnswer":75},"What conclusion does the meta-analysis support about NBAT-1?",{"text":76,"@type":64},"Reduced NBAT-1 expression can predict poor prognosis in several cancers, indicating NBAT-1 as a promising prognostic biomarker.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},335850,1790164618,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":116,"preview_page_count":4},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Yu etal. BMC Cancer (2024) 24:109  \n[https://doi.org/10.1186/s12885-023-11770-w](https://doi.org/10.1186/s12885-023-11770-w)  \nBMC Cancer  \n RESEARCH Open Access  \nExpression level and clinical significance of NBAT-1 in human cancers: a systematic review and meta-analysis  \nYang Yu1†, Kedi Fan2†, Tingting Ni1, Xun Lei Zhang1, Xiaoqin Su1 and Lei Yang1*  \nAbstract  \nPurpose There is an aberrant expression of NBAT-1 in various human cancers, which was proven to limit the proliferation, invasion, and metastasis of tumour cells via multiple approaches. Most existing research focuses on sample size and discrete outcomes. Thus, a quantitative meta-analysis was performed to elucidate the prognostic value of lncRNANBAT-1 expression in cancer patients.  \nMaterials and methods Using Web of Science and PubMed, two researchers independently identified relevant studies to explore the association between the pathological features of human cancers and NBAT-1 expression levels. Then two scholars conducted literature screening according to exclusion criteria and admission criteria, and finally conducted statistical analysis through data extraction with StataSE 12.0.  \nResults A total of 12 eligible studies with 1600 patients were included in the meta-analysis eventually. It is indicated that the low expression level of lncRNA NBAT-1 was closely related to distant metastasis [RR = 0 . 50, 95% CI (0 . 33, 0 . 76), and P = 0 . 00], deep tumour invasion [RR = 0 . 62, 95% CI (0 .49,0 . 80), and P = 0 . 00], poor histological grade [RR = 0 . 68, 95% CI (0 . 57, 0 . 81), and P = 0 . 00], advanced TNM stage [RR = 0 . 66, 95% CI (0 . 55, 0 . 79), and P = 0 . 00], large tumour volume[RR = 0 . 72, 95% CI (0 . 55, 0 . 93), and P = 0 . 01], and lymph node metastasis [RR = 0 . 62, 95% CI (0 .46, 0 . 84), and P = 0 . 00], suggesting that it may serve as biomarkers for patients with poor prognosis.  \nConclusion Reduced expression of NBAT-1 can predict poor prognosis in several cancers, as found in the meta-analysis, demonstrating that NBAT-1 can serve as a promising prognostic factor of human cancers.  \nKeywords Neoplasms, NBAT-1, Meta-analysis, Prognosis  \n†Yang Yu and Kedi Fan contributed equally to this work.  \n*Correspondence: Lei Yang [leiyang.53@163.com](leiyang.53@163.com)  \n1 Department of Oncology, Affiliated Tumour Hospital of Nantong University, Nantong, Jiangsu Province, People’s Republic of China  \n2 Department of Medical School, Nantong University, Nantong, Jiangsu Province, People’s Republic of China  \nIntroduction  \nCancer is one of the leading causes of death and oneof public health barriers that threatens human health worldwide. According to estimates by the World Health Organization (WHO) in 2019, cancer is the first or second leading cause of death in people under 70 years of age in 112 out of 183 countries, while it ranks third or fourth in another 23 countries [1]. In the latest Global Cancer Statistics, it is estimated that there will be 19.3 million new cases and 10 million cancer deaths worldwide in 2020 [1]. Therefore, there is an urgent need to find a new effective biomarker that can be used to predict  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creative","cbCaijzcPmz4PBs5","https://ap.wps.com/l/cbCaijzcPmz4PBs5","pdf",2384511,12,"English","# Abstract\n## Purpose\n## Materials and methods\n## Results\n## Conclusion\n# Introduction\n## Background on cancer burden\n## Role of noncoding RNAs and lncRNAs","[{\"question\":\"What was the goal of the systematic review and meta-analysis?\",\"answer\":\"To determine the prognostic value of lncRNA NBAT-1 expression in cancer patients by quantifying its association with clinical features and outcomes.\"},{\"question\":\"How were studies identified and selected?\",\"answer\":\"Two researchers independently searched Web of Science and PubMed, then performed literature screening using exclusion and admission criteria, followed by data extraction and statistical analysis in StataSE 12.0.\"},{\"question\":\"Which clinical factors were associated with low NBAT-1 expression?\",\"answer\":\"Low NBAT-1 expression correlated with distant metastasis, deep tumor invasion, poor histological grade, advanced TNM stage, larger tumor volume, and lymph node metastasis.\"},{\"question\":\"What conclusion does the meta-analysis support about NBAT-1?\",\"answer\":\"Reduced NBAT-1 expression can predict poor prognosis in several cancers, indicating NBAT-1 as a promising prognostic biomarker.\"}]","Expression level and clinical significance of NBAT-1 in human cancers - a systematic review and meta-analysis | PDF",1790012587]